ROSANO, GIUSEPPE MASSIMO CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 1.501
AS - Asia 1.260
EU - Europa 376
SA - Sud America 190
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 3
Totale 3.353
Nazione #
US - Stati Uniti d'America 1.376
SG - Singapore 432
CN - Cina 369
TR - Turchia 279
BR - Brasile 163
IT - Italia 135
CA - Canada 105
VN - Vietnam 69
DE - Germania 64
UA - Ucraina 43
HK - Hong Kong 32
GB - Regno Unito 30
IN - India 19
RU - Federazione Russa 18
PL - Polonia 16
MX - Messico 15
NL - Olanda 15
JP - Giappone 12
EU - Europa 11
FR - Francia 11
SE - Svezia 11
ID - Indonesia 10
IE - Irlanda 10
AR - Argentina 8
BD - Bangladesh 7
CO - Colombia 6
EC - Ecuador 6
ES - Italia 6
FI - Finlandia 6
IQ - Iraq 5
ZA - Sudafrica 5
KE - Kenya 4
PK - Pakistan 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
LB - Libano 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
LT - Lituania 2
MY - Malesia 2
RO - Romania 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
VE - Venezuela 2
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HN - Honduras 1
JO - Giordania 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 3.353
Città #
Dallas 369
Singapore 161
Santa Clara 154
San Mateo 147
Kocaeli 145
Toronto 84
Beijing 72
Ashburn 67
Houston 53
Rome 51
Shanghai 50
Chandler 44
Wilmington 41
Frankfurt am Main 34
Hong Kong 32
Guangzhou 28
Ho Chi Minh City 28
Lawrence 28
Los Angeles 28
Princeton 28
West Jordan 28
São Paulo 26
Warsaw 16
Boston 15
Hanoi 15
Seattle 14
Munich 13
New York 13
Council Bluffs 12
Tokyo 12
Assago 10
Chicago 10
Fairfield 10
Shenzhen 10
Atlanta 9
Montreal 9
Brooklyn 8
Milan 8
Stockholm 8
Wandsworth 8
Woodbridge 8
Boardman 6
Buffalo 6
Cambridge 6
Chennai 6
Manchester 6
Mexico City 6
San Francisco 6
The Dalles 6
Wuhan 6
Campinas 5
Charlotte 5
Cremona 5
Johannesburg 5
Phoenix 5
Rio de Janeiro 5
Rui'an 5
Wuxi 5
Xi'an 5
Amsterdam 4
Dublin 4
Jakarta 4
Nairobi 4
Ottawa 4
Tashkent 4
Verona 4
Belo Horizonte 3
Brasília 3
Cassino 3
Curitiba 3
Denver 3
Helsinki 3
Jinhua 3
London 3
Medan 3
Nantong 3
New Delhi 3
Paris 3
Pune 3
Quito 3
São Gonçalo 3
Thái Bình 3
Turin 3
Turku 3
Andover 2
Aversa 2
Barbacena 2
Belford Roxo 2
Biên Hòa 2
Bogotá 2
Cariacica 2
Cincinnati 2
Cisterna di Latina 2
Ciudad del Este 2
Columbus 2
Contagem 2
Da Nang 2
Florence 2
Fortaleza 2
Fresno 2
Totale 2.119
Nome #
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 111
Bisphosphonates and adipogenesis: Evidence for alendronate inhibition of adipocyte differentiation in 3T3-L1 preadipocytes through a vitamin D receptor mediated effect 67
MINERALCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CORTICOID-INDUCED OBESITY 63
Cellular Models for Understanding Adipogenesis, Adipose Dysfunction, and Obesity 61
Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure 59
Mineralocorticoid receptor in adipocytes and macrophages: A promising target to fight metabolic syndrome 55
Essential role of ICAM-1 in aldosterone-induced atherosclerosis 54
Androgens and Adipose Tissue in Males: A Complex and Reciprocal Interplay 52
Tai chi enhances the effects of endurance training in the rehabilitation of elderly patients with chronic heart failure. 51
Androgens and cardiovascular disease: gender-related differences 50
Erratum to: Comparison of Microlife BP A200 Plus and Omron M6 Blood Pressure Monitors to Detect Atrial Fibrillation in Hypertensive Patients 50
Anticoagulation in "real world" patients with atrial fibrillation in Italy: Results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study 47
Endothelial effects of drugs designed to treat erectile dysfunction 45
The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism 44
Potential role of progestogens in the control of adipose tissue and salt sensitivity via interaction with the mineralocorticoid receptor 44
The mineralocorticoid receptor in endothelial physiology and disease: novel concepts in the understanding of erectile dysfunction 44
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology 44
Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice 42
A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose 42
Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs 40
Mineralocorticoid vs glucocorticoid receptors: solo players or team mates in the control of adipogenesis? 40
Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion 39
Phosphodiesterase type 5 (PDE5) in the adipocyte: a novel player in fat metabolism? 39
Exposure to Phosphodiesterase Type 5 Inhibitors Stimulates Aromatase Expression in Human Adipocytes in vitro 39
Vitamin D: a novel player in endothelial function and dysfunction 39
Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity 38
On-target antihypertensive treatment in Italy: The ISPIT (Indagine Sicoa Paziente Iperteso a Target) survey study 38
International validation of the Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) score in heart failure 37
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure 35
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology 35
Physical Training Reduces the Ability of Serum from Patients with Heart Failure to Induce Endothelial Cell Death 33
Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib 33
Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure 32
Effects of a short-term exercise training on serum factors involved in ventricular remodelling in chronic heart failure patients 32
Drug Layering in Heart Failure: Phenotype-Guided Initiation 31
Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial). 31
Effect of exercise training on serum capacity to induce endothelial cell death in patients with chronic heart failure 30
Effects of Nebivolol versus Carvedilol in Hypertensive Patients with Chronic Heart Failure 30
Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance 30
Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT 30
ATP secreted by endothelial cells blocks CX₃CL 1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y₁₁ receptor activation 29
From glucose lowering to treatment of cardiovascular disease: the repositioning of glucose-lowering agents 29
Hydrotherapy added to endurance training versus endurance training alone in elderly patients with chronic heart failure: A randomized pilot study. 29
Trimetazidine improves exercise performance in patients with peripheral arterial disease 28
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology(ESC>) 27
Cardiac Metabolism in Myocardial Ischemia 26
COMPARISON BETWEEN INTERVAL TRAINING AND ENDURAND TRAINING ON 24-H BLOOD PRESSURE AND GLUCOSE METABOLISM IN HYPERTENSIVE PATIENTS WITH HEART FAILURE: A PILOT STUDY 26
Tricuspid annular plane systolic excursion is related to performance at six minute walking test in patients with heart failure undergoing exercise training. 26
MR antagonists protect against diet induced obesity and cardiac inflammation in mice, through browning of the adipose tissue and modulation of autophagy 26
Efficacy and safety of mineralocorticoid receptors in mild to moderate arterial hypertension. 25
Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients 24
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure 24
CXCL12 prolongs naive CD4+ T lymphocytes survival via activation of PKA, CREB and Bcl2 and BclXl up-regulation 24
Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review 24
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 23
Ranolazine 23
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology 23
Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. 22
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology 22
Menopause and cardiovascular disease: the evidence. Rosano GM, Vitale C, Marazzi G, Volterrani M 22
Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease. 21
Intensive cardiac rehabilitation improves glucometabolic state of non-diabetic patients with recent coronary artery bypass grafting 21
Anabolic hormonal response to different exercise training intensities in men with chronic heart failure 21
Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT 20
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 20
Clinical utility of ivabradine in cardiovascular disease management: current status 20
Atorvastatin attenuates post-implant tissue degeneration of cardiac prosthetic valve bovine pericardial tissue in a subcutaneous animal model. 20
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies 20
The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice 20
Dose-response relationship of baroreflex sensitivity and heart rate variability to individually-tailored exercise training in patients with heart failure 20
Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women. 19
Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review- From the Optimal Nutraceutical Supplementation in Heart Failure (Onus-HF) Working Group. 19
Effect of High-Intensity interval training versus moderate continuous training on 24-h blood pressure profile and insulin resistance in patients with chronic heart failure. 19
Metabolic syndrome predicts lower functional recovery in female but not in male patients after an acute cardiac event. 19
Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes. A 19
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 19
Corrigendum to "Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance" [Int. J. Cardiol. 202 (2016) 76-77] 18
Usefulness of Low-Dose Statin Plus Ezetimibe and/or Nutraceuticals in Patients With Coronary Artery Disease Intolerant to High-Dose Statin Treatment 18
Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity 18
Validation of rate of perceived exertion-based exercise training in patients with heart failure: Insights from autonomic nervous system adaptations. 17
Low testosterone levels are associated with coronary artery disease in male patients with angina. 17
Estrogen acutely increases peripheral blood flow in postmenopausal women. 17
Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease 17
Immunoregulation through extracellular nucleotides 17
Modulating the metabolism by trimetazidine enhances myoblast differentiation and promotes myogenesis in cachectic tumor-bearing c26 mice 17
Pre‐discharge and early post‐discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC 17
Role of leucocyte count and thyroid-stimulating hormone in evolution of mild cognitive impairment to dementia 16
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 16
Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome 16
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association and the European Heart Rhythm Association of the European Society of Cardiology and the the European Society of Hypertension 16
Comparison of Low-Dose Statin Versus Low-Dose Statin+Armolipid Plus in High-Intensity Statin-Intolerant Patients With a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial) 16
Ranolazine improves insulin resistance in non-diabetic patients with coronary heart disease. A pilot study. 16
Mineralocorticoid receptor activation affects skeletal muscle development and metabolism. 16
Mineralocorticoid receptor in adipocytes and macrophages: a promising target to fight metabolic syndrome 16
Effectiveness of nebivolol and hydrochlorothiazide association on blood pressure, glucose, and lipid metabolism in hypertensive patients. 15
Effects of testosterone on the Q-T Interval in older men and older women with chronic heart failure. 15
The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubes 15
New Therapeutics for Heart Failure Worsening: Focus on Vericiguat 15
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. 15
Testosterone and heart failure. 14
Totale 2.965
Categoria #
all - tutte 44.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021241 0 0 0 4 7 22 15 8 12 9 148 16
2021/2022288 1 82 83 8 0 0 18 28 5 58 2 3
2022/2023245 61 1 3 14 11 17 0 13 9 93 19 4
2023/2024343 4 0 10 32 9 14 1 22 4 59 14 174
2024/20251.247 93 287 50 30 49 174 57 68 187 17 58 177
2025/20261.027 268 246 298 215 0 0 0 0 0 0 0 0
Totale 3.508